1
|
Lou T, Chen K, Luo Q, Liu C, Yuan Y, Fan C. Periosteum-inspired in situ CaP generated nanocomposite hydrogels with strong bone adhesion and superior stretchability for accelerated distraction osteogenesis. Biomater Res 2022; 26:91. [PMID: 36581951 PMCID: PMC9801553 DOI: 10.1186/s40824-022-00330-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2022] [Accepted: 11/27/2022] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND Distraction osteogenesis (DO) is an efficacious but lengthy procedure to reconstruct segmental bone defects under the principle of tension-stress, during which the periosteum-mediated mechanical stimulation plays a pivotal role. Inspired by the dynamic process of DO and the mechanical stimulation of periosteum, a new design of bionic periosteum was developed to simulate the mechanical transduction of natural periosteum for the application in DO procedure. METHODS In this study, an injectable organic-inorganic hybrid hydrogel was developed based on a novel combination of the PEGylated poly (glycerol sebacate) (PEGS) polymer network and in situ formed CaP nanoparticles (ICPNs). Rat bone marrow mesenchymal stem cells (rBMSCs) and human umbilical vein endothelial cells (HUVECs) were cultured and tested in vitro to evaluate biocompatibility, cell adhesion, proliferation, and pro-osteogenic and pro-angiogenic activity. In vivo experiments were conducted in the rat tibial model of distraction osteogenesis. RESULTS The developed nanocomposite hydrogels exhibited excellent injectability, robust bone adhesion, superior stretchability, and enhanced osteogenic activity. The results of in vitro and in vivo studies showed that PEGS/ICPN hydrogels could promote new bone formation and mineralization during the dynamic distraction process through the synergistic effects of angiogenesis and osteogenesis. CONCLUSIONS This periosteum-inspired nanocomposite hydrogel represents a mechanobiology approach for effectively restoring large bone defects through the dynamic DO process.
Collapse
Affiliation(s)
- Tengfei Lou
- grid.412528.80000 0004 1798 5117Orthopaedic Department, Shanghai Sixth People’s Hospital, Shanghai, 200233 People’s Republic of China
| | - Kai Chen
- grid.28056.390000 0001 2163 4895Key Laboratory for Ultrafine Materials of Ministry of Education, and School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, 200237 People’s Republic of China ,grid.28056.390000 0001 2163 4895Frontiers Science Center for Materiobiology and Dynamic Chemistry, and Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai, 200237 People’s Republic of China
| | - Qiyu Luo
- grid.412528.80000 0004 1798 5117Orthopaedic Department, Shanghai Sixth People’s Hospital, Shanghai, 200233 People’s Republic of China
| | - Changsheng Liu
- grid.28056.390000 0001 2163 4895Key Laboratory for Ultrafine Materials of Ministry of Education, and School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, 200237 People’s Republic of China ,grid.28056.390000 0001 2163 4895Frontiers Science Center for Materiobiology and Dynamic Chemistry, and Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai, 200237 People’s Republic of China
| | - Yuan Yuan
- grid.28056.390000 0001 2163 4895Key Laboratory for Ultrafine Materials of Ministry of Education, and School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, 200237 People’s Republic of China ,grid.28056.390000 0001 2163 4895Frontiers Science Center for Materiobiology and Dynamic Chemistry, and Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai, 200237 People’s Republic of China
| | - Cunyi Fan
- grid.412528.80000 0004 1798 5117Orthopaedic Department, Shanghai Sixth People’s Hospital, Shanghai, 200233 People’s Republic of China
| |
Collapse
|
2
|
Tee BC, Sun Z. Xenogeneic mesenchymal stem cell transplantation for mandibular defect regeneration. Xenotransplantation 2020; 27:e12625. [PMID: 32629548 DOI: 10.1111/xen.12625] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 03/18/2020] [Accepted: 06/06/2020] [Indexed: 12/28/2022]
Abstract
BACKGROUND It is commonly accepted that xenogeneic stem cell transplantation for tissue engineering is faced with host immune rejection. Using a rat critical-size mandibular defect model, this study examined whether the immune rejection can be evaded by diminishing T-cell immunity. METHODS To examine donor cell survival and host immune reaction, pig bone marrow-derived mesenchymal stem cells (BM-MSCs) were labeled with CM-DiI, loaded onto gelatin sponge (5 × 106 cells/scaffold), and transplanted into 5-mm mandibular defects of immunocompetent and T cell-deficient athymic rats. To examine the effects of xenogeneic BM-MSCs on bone regeneration, athymic rats undergone the same surgeries were terminated at post-operative weeks 1, 3, and 6. Control rats underwent the same jaw surgery without BM-MSC transplantation. RESULTS The density of CM-DiI-labeled BM-MSCs decreased with time in both strains of rats. Although it was substantially higher in athymic rats than in immunocompetent rats at post-operative day 1, by day 3-7 the density became comparable between the two strains of rats. Apoptosis reflected by cleaved Caspase-3 staining was low in both strains. Stronger infiltration of neutrophils, macrophages, B cells and CD8+ T cells was found in MSC-treated animals. In athymic rats, infiltration of neutrophils and macrophages was strong, but it occurred later than that in immunocompetent rats. While bone volume fraction significantly increased with time (P < .001), no difference was found between MSC-treated and control groups. CONCLUSIONS Even in hosts with deficient T-cell immunity, xenogeneic BM-MSC transplantation into mandibular critical-sized defects still faces challenges from host innate immunity, which compromises their regenerative efficacy.
Collapse
Affiliation(s)
- Boon Ching Tee
- Division of Biosciences, College of Dentistry, The Ohio State University, Columbus, OH, USA
| | - Zongyang Sun
- Division of Orthodontics, College of Dentistry, The Ohio State University, Columbus, OH, USA
| |
Collapse
|
3
|
Böhrnsen F, Melsheimer P, Natorp M, Rolf H, Schminke B, Kauffmann P, Wolfer S, Schliephake H. Cotransplantation of mesenchymal stromal cells and endothelial cells on calcium carbonate and hydroxylapatite scaffolds in vivo. J Craniomaxillofac Surg 2020; 49:238-245. [PMID: 33483245 DOI: 10.1016/j.jcms.2020.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Revised: 02/06/2020] [Accepted: 03/08/2020] [Indexed: 10/24/2022] Open
Abstract
This study investigated the cotransplantation of bone marrow mesenchymal stromal cells (BMSC) and human umbilical cord endothelial cells (HUVEC), and evaluated their contribution to vascular and bone tissue engineering in vivo. To evaluate the success of osteogenic differentiation and timely vascularization of different osteoconductive scaffolds in vivo, we transferred BMSC and HUVEC pre-cultivated calcium carbonate (CaCO3) and hydroxylapatite (HA) matrices into immunocompromised RNU-rats, and analyzed mineralization, expression of osteopontin, and vascular integration via new vessel formation. After in vivo transplantation, pre-cultivated scaffolds demonstrated overall improved mineralization of 44% for CaCO3 (p = 0.01, SD ± 14.3) and 34% for HA (p = 0.001, SD ± 17.8), as well as improved vascularization of 5.6 vessels/0.1 mm2 on CaCO3 (p < 0.0001, SD ± 2.0) and 5.3 vessels/0.1 mm2 on HA (p < 0.0001, SD ± 2.4) compared with non-pre-cultivated controls. However, no significant differences between the implantation of BMSC-only, HUVEC-only, or BMSC + HUVEC cocultures could be observed. There is an increasing demand for improved bone regeneration in tissue engineering. Cotransplantation of mesenchymal stromal cells and endothelial cells often demonstrates synergistic improvements in vitro. However, the benefits or superiority of cotransplantation was not evident in vivo and so will require further investigation.
Collapse
Affiliation(s)
- Florian Böhrnsen
- Department of Oral and Maxillofacial Surgery, University Medicine Göttingen, Germany.
| | - Petra Melsheimer
- Department of Oral and Maxillofacial Surgery, University Medicine Göttingen, Germany
| | - Mareike Natorp
- Department of Oral and Maxillofacial Surgery, University Medicine Göttingen, Germany
| | - Hans Rolf
- Department of Oral and Maxillofacial Surgery, University Medicine Göttingen, Germany
| | - Boris Schminke
- Department of Oral and Maxillofacial Surgery, University Medicine Göttingen, Germany
| | - Philipp Kauffmann
- Department of Oral and Maxillofacial Surgery, University Medicine Göttingen, Germany
| | - Susanne Wolfer
- Department of Oral and Maxillofacial Surgery, University Medicine Göttingen, Germany
| | - Henning Schliephake
- Department of Oral and Maxillofacial Surgery, University Medicine Göttingen, Germany
| |
Collapse
|
4
|
Wu Y, Fu R, Mohanty S, Nasser M, Guo B, Ghosh G. Investigation of Integrated Effects of Hydroxyapatite and VEGF on Capillary Morphogenesis of Endothelial Cells. ACS APPLIED BIO MATERIALS 2019; 2:2339-2346. [DOI: 10.1021/acsabm.8b00780] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Yang Wu
- Bioengineering Program, Department of Mechanical Engineering, University of Michigan, Dearborn, 4901 Evergreen Road, Dearborn, Michigan 48128, United States
| | - Rong Fu
- Bioengineering Program, Department of Mechanical Engineering, University of Michigan, Dearborn, 4901 Evergreen Road, Dearborn, Michigan 48128, United States
| | - Swetaparna Mohanty
- Bioengineering Program, Department of Mechanical Engineering, University of Michigan, Dearborn, 4901 Evergreen Road, Dearborn, Michigan 48128, United States
| | - Malak Nasser
- Bioengineering Program, Department of Mechanical Engineering, University of Michigan, Dearborn, 4901 Evergreen Road, Dearborn, Michigan 48128, United States
| | - Bingxin Guo
- Bioengineering Program, Department of Mechanical Engineering, University of Michigan, Dearborn, 4901 Evergreen Road, Dearborn, Michigan 48128, United States
| | - Gargi Ghosh
- Bioengineering Program, Department of Mechanical Engineering, University of Michigan, Dearborn, 4901 Evergreen Road, Dearborn, Michigan 48128, United States
| |
Collapse
|
5
|
Paschalaki KE, Randi AM. Recent Advances in Endothelial Colony Forming Cells Toward Their Use in Clinical Translation. Front Med (Lausanne) 2018; 5:295. [PMID: 30406106 PMCID: PMC6205967 DOI: 10.3389/fmed.2018.00295] [Citation(s) in RCA: 69] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Accepted: 09/28/2018] [Indexed: 12/17/2022] Open
Abstract
The term “Endothelial progenitor cell” (EPC) has been used to describe multiple cell populations that express endothelial surface makers and promote vascularisation. However, the only population that has all the characteristics of a real “EPC” is the Endothelial Colony Forming Cells (ECFC). ECFC possess clonal proliferative potential, display endothelial and not myeloid cell surface markers, and exhibit pronounced postnatal vascularisation ability in vivo. ECFC have been used to investigate endothelial molecular dysfunction in several diseases, as they give access to endothelial cells from patients in a non-invasive way. ECFC also represent a promising tool for revascularization of damaged tissue. Here we review the translational applications of ECFC research. We discuss studies which have used ECFC to investigate molecular endothelial abnormalities in several diseases and review the evidence supporting the use of ECFC for autologous cell therapy, gene therapy and tissue regeneration. Finally, we discuss ways to improve the therapeutic efficacy of ECFC in clinical applications, as well as the challenges that must be overcome to use ECFC in clinical trials for regenerative approaches.
Collapse
Affiliation(s)
- Koralia E Paschalaki
- Vascular Sciences, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom
| | - Anna M Randi
- Vascular Sciences, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom
| |
Collapse
|
6
|
Chu L, Jiang G, Hu XL, James TD, He XP, Li Y, Tang T. Biodegradable macroporous scaffold with nano-crystal surface microstructure for highly effective osteogenesis and vascularization. J Mater Chem B 2018; 6:1658-1667. [PMID: 32254282 DOI: 10.1039/c7tb03353b] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Using the hydrothermal calcination method, bovine cancellous bone was transformed into a degradable macroporous scaffold with a nano-crystal surface microstructure, capable of releasing bioactive ions. Compared with the control group, the presence of the nano-crystal microstructure of the material scaffold significantly promoted the gene expression of adhesion proteins including integrin and vinculin, thus facilitating attachment, spreading, proliferation and focal adhesion formation of MC3T3-E1 cells on the surface of the scaffold. Additionally, the release of active magnesium and calcium ions from the scaffold promoted expression of osteogenic genes and formation of calcium nodules in osteoblasts. Both in vitro and in vivo assays demonstrated that the three-dimensional interconnected porous architecture promoted vascularization and tissue integration. Our findings provide new insight into the development of degradable macroporous composite materials with "three-dimensional" surface microstructures as bone substitutes or tissue engineering scaffolds with potential for clinical applications.
Collapse
Affiliation(s)
- Linyang Chu
- Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.
| | | | | | | | | | | | | |
Collapse
|
7
|
Mitra D, Whitehead J, Yasui OW, Leach JK. Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells. Biomaterials 2017; 146:29-39. [PMID: 28898756 PMCID: PMC5618709 DOI: 10.1016/j.biomaterials.2017.08.044] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2017] [Revised: 08/24/2017] [Accepted: 08/25/2017] [Indexed: 11/20/2022]
Abstract
Perfusion culture of mesenchymal stem cells (MSCs) seeded in biomaterial scaffolds provides nutrients for cell survival, enhances extracellular matrix deposition, and increases osteogenic cell differentiation. However, there is no consensus on the appropriate perfusion duration of cellular constructs in vitro to boost their bone forming capacity in vivo. We investigated this phenomenon by culturing human MSCs in macroporous composite scaffolds in a direct perfusion bioreactor and compared their response to scaffolds in continuous dynamic culture conditions on an XYZ shaker. Cell seeding in continuous perfusion bioreactors resulted in more uniform MSC distribution than static seeding. We observed similar calcium deposition in all composite scaffolds over 21 days of bioreactor culture, regardless of pore size. Compared to scaffolds in dynamic culture, perfused scaffolds exhibited increased DNA content and expression of osteogenic markers up to 14 days in culture that plateaued thereafter. We then evaluated the effect of perfusion culture duration on bone formation when MSC-seeded scaffolds were implanted in a murine ectopic site. Human MSCs persisted in all scaffolds at 2 weeks in vivo, and we observed increased neovascularization in constructs cultured under perfusion for 7 days relative to those cultured for 1 day within each gender. At 8 weeks post-implantation, we observed greater bone volume fraction, bone mineral density, tissue ingrowth, collagen density, and osteoblastic markers in bioreactor constructs cultured for 14 days compared to those cultured for 1 or 7 days, and acellular constructs. Taken together, these data demonstrate that culturing MSCs under perfusion culture for at least 14 days in vitro improves the quantity and quality of bone formation in vivo. This study highlights the need for optimizing in vitro bioreactor culture duration of engineered constructs to achieve the desired level of bone formation.
Collapse
Affiliation(s)
- Debika Mitra
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA
| | - Jacklyn Whitehead
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA
| | - Osamu W Yasui
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA
| | - J Kent Leach
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA; Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA.
| |
Collapse
|
8
|
The Effects of Adipose-Derived Stem Cells Differentiated Into Endothelial Cells and Osteoblasts on Healing of Critical Size Calvarial Defects. J Craniofac Surg 2017; 28:1874-1879. [DOI: 10.1097/scs.0000000000003910] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
9
|
Westhauser F, Senger AS, Reible B, Moghaddam A. * In Vivo Models for the Evaluation of the Osteogenic Potency of Bone Substitutes Seeded with Mesenchymal Stem Cells of Human Origin: A Concise Review. Tissue Eng Part C Methods 2017; 23:881-888. [PMID: 28747099 DOI: 10.1089/ten.tec.2017.0164] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
Research concerning bone substitutes is one of the most challenging fields in orthopedic research and has a high clinical relevance, especially since the currently available bone substitutes are limited in their osteostimulative capabilities. In vitro models for the evaluation of the properties of bone substitutes allow the use of human mesenchymal stem cells (hMSCs) seeded onto scaffolds, but suffer from the lack of a physiological environment for those cells. Most in vivo models include the use of non-hMSC and are therefore lacking in clinical relevance. To overcome these issues, in vivo models were created that allow the evaluation of hMSC-seeded bone substitutes, combining the advantages of the use of human cells with the physiological conditions of an organism in vivo. In brief, models usually aim for bone formation in immunocompromised rodents. The subcutaneous implantation of scaffolds is most widely performed, showing low complication rates along with good results, but suffering from inferior vascularization of the implants and the absence of the realistic structural and mechanical conditions of bone. Orthotopic implantation, for example in calvarian or long bone defects, provides the most appropriate surrounding for hMSC-seeded scaffolds. However, parallel host-induced bone formation is a major limitation. This review summarizes in vivo models for the evaluation of the osteogenic potency of bone substitutes seeded with mesenchymal stem cells of human origin.
Collapse
Affiliation(s)
- Fabian Westhauser
- 1 HTRG-Heidelberg Trauma Research Group, Center of Orthopedics, Traumatology, and Spinal Cord Injury, Heidelberg University Hospital , Heidelberg, Germany
| | - Anne-Sophie Senger
- 1 HTRG-Heidelberg Trauma Research Group, Center of Orthopedics, Traumatology, and Spinal Cord Injury, Heidelberg University Hospital , Heidelberg, Germany
| | - Bruno Reible
- 1 HTRG-Heidelberg Trauma Research Group, Center of Orthopedics, Traumatology, and Spinal Cord Injury, Heidelberg University Hospital , Heidelberg, Germany
| | - Arash Moghaddam
- 2 Clinic for Orthopedic Surgery, Trauma Surgery, and Hand Surgery, Klinikum Aschaffenburg-Alzenau , Aschaffenburg, Germany
| |
Collapse
|
10
|
Rioja AY, Daley ELH, Habif JC, Putnam AJ, Stegemann JP. Distributed vasculogenesis from modular agarose-hydroxyapatite-fibrinogen microbeads. Acta Biomater 2017; 55:144-152. [PMID: 28365482 DOI: 10.1016/j.actbio.2017.03.050] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2017] [Revised: 03/03/2017] [Accepted: 03/28/2017] [Indexed: 11/29/2022]
Abstract
Critical limb ischemia impairs circulation to the extremities, causing pain, disrupted wound healing, and potential tissue necrosis. Therapeutic angiogenesis seeks to repair the damaged microvasculature directly to restore blood flow. In this study, we developed modular, micro-scale constructs designed to possess robust handling qualities, allow in vitro pre-culture, and promote microvasculature formation. The microbead matrix consisted of an agarose (AG) base to prevent aggregation, combined with cell-adhesive components of fibrinogen (FGN) and/or hydroxyapatite (HA). Microbeads encapsulating a co-culture of human umbilical vein endothelial cells (HUVEC) and fibroblasts were prepared and characterized. Microbeads were generally 80-100µm in diameter, and the size increased with the addition of FGN and HA. Addition of HA increased the yield of microbeads, as well as the homogeneity of distribution of FGN within the matrix. Cell viability was high in all microbead types. When cell-seeded microbeads were embedded in fibrin hydrogels, HUVEC sprouting and inosculation between neighboring microbeads were observed over seven days. Pre-culture of microbeads for an additional seven days prior to embedding in fibrin resulted in significantly greater HUVEC network length in AG+HA+FGN microbeads, as compared to AG, AG+HA or AG+FGN microbeads. Importantly, composite microbeads resulted in more even and widespread endothelial network formation, relative to control microbeads consisting of pure fibrin. These results demonstrate that AG+HA+FGN microbeads support HUVEC sprouting both within and between adjacent microbeads, and can promote distributed vascularization of an external matrix. Such modular microtissues may have utility in treating ischemic tissue by rapidly re-establishing a microvascular network. STATEMENT OF SIGNIFICANCE Critical limb ischemia (CLI) is a chronic disease that can lead to tissue necrosis, amputation, and death. Cell-based therapies are being explored to restore blood flow and prevent the complications of CLI. In this study, we developed small, non-aggregating agarose-hydroxyapatite-fibrinogen microbeads that contained endothelial cells and fibroblasts. Microbeads were easy to handle and culture, and endothelial sprouts formed within and between microbeads. Our data demonstrates that the composition of the microbead matrix altered the degree of endothelial sprouting, and that the addition of hydroxyapatite and fibrinogen resulted in more distributed sprouting compared to pure fibrin microbeads. The microbead format and control of the matrix formulation may therefore be useful in developing revascularization strategies for the treatment of ischemic disease.
Collapse
Affiliation(s)
- Ana Y Rioja
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States
| | - Ethan L H Daley
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States
| | - Julia C Habif
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States
| | - Andrew J Putnam
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States
| | - Jan P Stegemann
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
| |
Collapse
|
11
|
Shanbhag S, Pandis N, Mustafa K, Nyengaard JR, Stavropoulos A. Cell Cotransplantation Strategies for Vascularized Craniofacial Bone Tissue Engineering: A Systematic Review and Meta-Analysis of Preclinical In Vivo Studies. TISSUE ENGINEERING PART B-REVIEWS 2016; 23:101-117. [PMID: 27733094 DOI: 10.1089/ten.teb.2016.0283] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
The regenerative potential of tissue-engineered bone constructs may be enhanced by in vitro coculture and in vivo cotransplantation of vasculogenic and osteogenic (progenitor) cells. The objective of this study was to systematically review the literature to answer the focused question: In animal models, does cotransplantation of osteogenic and vasculogenic cells enhance bone regeneration in craniofacial defects, compared with solely osteogenic cell-seeded constructs? Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, electronic databases were searched for controlled animal studies reporting cotransplantation of endothelial cells (ECs) with mesenchymal stem cells (MSCs) or osteoblasts in craniofacial critical size defect (CSD) models. Twenty-two studies were included comparing outcomes of MSC/scaffold versus MSC+EC/scaffold (co)transplantation in calvarial (n = 15) or alveolar (n = 7) CSDs of small (rodents, rabbits) and large animal (minipigs, dogs) models. On average, studies presented with an unclear to high risk of bias. MSCs were derived from autologous, allogeneic, xenogeneic, or human (bone marrow, adipose tissue, periosteum) sources; in six studies, ECs were derived from MSCs by endothelial differentiation. In most studies, MSCs and ECs were cocultured in vitro (2-17 days) before implantation. Coculture enhanced MSC osteogenic differentiation and an optimal MSC:EC seeding ratio of 1:1 was identified. Alloplastic copolymer or composite scaffolds were most often used for in vivo implantation. Random effects meta-analyses were performed for histomorphometric and radiographic new bone formation (%NBF) and vessel formation in rodents' calvarial CSDs. A statistically significant benefit in favor of cotransplantation versus MSC-only transplantation for radiographic %NBF was observed in rat calvarial CSDs (weighted mean difference 7.80% [95% confidence interval: 1.39-14.21]); results for histomorphometric %NBF and vessel formation were inconclusive. Overall, heterogeneity in the meta-analyses was high (I2 > 80%). In summary, craniofacial bone regeneration is enhanced by cotransplantation of vasculogenic and osteogenic cells. Although the direction of treatment outcome is in favor of cotransplantation strategies, the magnitude of treatment effect does not seem to be of relevance, unless proven otherwise in clinical studies.
Collapse
Affiliation(s)
- Siddharth Shanbhag
- 1 Department of Clinical Dentistry, Centre for Clinical Dental Research, University of Bergen , Bergen, Norway .,2 Department of Periodontology, Faculty of Odontology, Malmö University , Malmö, Sweden
| | - Nikolaos Pandis
- 3 Department of Orthodontics and Dentofacial Orthopedics, School of Dental Medicine, University of Bern , Bern, Switzerland
| | - Kamal Mustafa
- 1 Department of Clinical Dentistry, Centre for Clinical Dental Research, University of Bergen , Bergen, Norway
| | - Jens R Nyengaard
- 4 Stereology and Electron Microscopy Laboratory, Department of Clinical Medicine, Aarhus University , Aarhus, Denmark
| | - Andreas Stavropoulos
- 2 Department of Periodontology, Faculty of Odontology, Malmö University , Malmö, Sweden
| |
Collapse
|
12
|
Ho SS, Vollmer NL, Refaat MI, Jeon O, Alsberg E, Lee MA, Leach JK. Bone Morphogenetic Protein-2 Promotes Human Mesenchymal Stem Cell Survival and Resultant Bone Formation When Entrapped in Photocrosslinked Alginate Hydrogels. Adv Healthc Mater 2016; 5:2501-2509. [PMID: 27581621 PMCID: PMC5176258 DOI: 10.1002/adhm.201600461] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2016] [Revised: 07/13/2016] [Indexed: 12/15/2022]
Abstract
There is a substantial need to prolong cell persistence and enhance functionality in situ to enhance cell-based tissue repair. Bone morphogenetic protein-2 (BMP-2) is often used at high concentrations for osteogenic differentiation of mesenchymal stem cells (MSCs) but can induce apoptosis. Biomaterials facilitate the delivery of lower doses of BMP-2, reducing side effects and localizing materials at target sites. Photocrosslinked alginate hydrogels (PAHs) can deliver osteogenic materials to irregular-sized bone defects, providing improved control over material degradation compared to ionically cross-linked hydrogels. It is hypothesized that the delivery of MSCs and BMP-2 from a PAH increases cell persistence by reducing apoptosis, while promoting osteogenic differentiation and enhancing bone formation compared to MSCs in PAHs without BMP-2. BMP-2 significantly decreases apoptosis and enhances survival of photoencapsulated MSCs, while simultaneously promoting osteogenic differentiation in vitro. Bioluminescence imaging reveals increased MSC survival when implanted in BMP-2 PAHs. Bone defects treated with MSCs in BMP-2 PAHs demonstrate 100% union as early as 8 weeks and significantly higher bone volumes at 12 weeks, while defects with MSC-entrapped PAHs alone do not fully bridge. This study demonstrates that transplantation of MSCs with BMP-2 in PAHs achieves robust bone healing, providing a promising platform for bone repair.
Collapse
Affiliation(s)
- Steve S Ho
- Department of Biomedical Engineering, University of California, Davis 451 Health Sciences Drive, Davis, CA, 95616, USA
| | - Nina L Vollmer
- Department of Biomedical Engineering, University of California, Davis 451 Health Sciences Drive, Davis, CA, 95616, USA
| | - Motasem I Refaat
- Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, CA, 95817, USA
| | - Oju Jeon
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA
| | - Eben Alsberg
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA
- Department of Orthopaedic Surgery, Case Western Reserve University, Cleveland, OH, 44106, USA
| | - Mark A Lee
- Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, CA, 95817, USA
| | - J Kent Leach
- Department of Biomedical Engineering, University of California, Davis 451 Health Sciences Drive, Davis, CA, 95616, USA.
- Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, CA, 95817, USA.
| |
Collapse
|
13
|
Murphy KC, Hoch AI, Harvestine JN, Zhou D, Leach JK. Mesenchymal Stem Cell Spheroids Retain Osteogenic Phenotype Through α2β1 Signaling. Stem Cells Transl Med 2016; 5:1229-37. [PMID: 27365484 PMCID: PMC4996446 DOI: 10.5966/sctm.2015-0412] [Citation(s) in RCA: 52] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2015] [Accepted: 04/07/2016] [Indexed: 12/22/2022] Open
Abstract
The induction of mesenchymal stem cells (MSCs) toward the osteoblastic lineage using osteogenic supplements prior to implantation is one approach under examination to enhance their bone-forming potential. Spheroids formed from induced cells exhibited improved retention of osteogenic markers as a function of integrin binding to cell-secreted extracellular matrix (ECM). These results demonstrate the capacity of spheroidal culture to sustain the mineral-producing phenotype of MSCs, thus enhancing their contribution toward bone formation and repair. The induction of mesenchymal stem cells (MSCs) toward the osteoblastic lineage using osteogenic supplements prior to implantation is one approach under examination to enhance their bone-forming potential. MSCs rapidly lose their induced phenotype upon removal of the soluble stimuli; however, their bone-forming potential can be sustained when provided with continued instruction via extracellular matrix (ECM) cues. In comparison with dissociated cells, MSC spheroids exhibit improved survival and secretion of trophic factors while maintaining their osteogenic potential. We hypothesized that entrapment of MSC spheroids formed from osteogenically induced cells would exhibit better preservation of their bone-forming potential than would dissociated cells from monolayer culture. Spheroids exhibited comparable osteogenic potential and increased proangiogenic potential with or without osteogenic preconditioning versus monolayer-cultured MSCs. Spheroids were then entrapped in collagen hydrogels, and the osteogenic stimulus was removed. In comparison with entrapped dissociated MSCs, spheroids exhibited significantly increased markers of osteogenic differentiation. The capacity of MSC spheroids to retain their osteogenic phenotype upon withdrawal of inductive cues was mediated by α2β1 integrin binding to cell-secreted ECM. These results demonstrate the capacity of spheroidal culture to sustain the mineral-producing phenotype of MSCs, thus enhancing their contribution toward bone formation and repair. Significance Despite the promise of mesenchymal stem cells (MSCs) for cell-based therapies for tissue repair and regeneration, there is little evidence that transplanted MSCs directly contribute to new bone formation, suggesting that induced cells rapidly lose their osteogenic phenotype or undergo apoptosis. In comparison with dissociated cells, MSC spheroids exhibit increased trophic factor secretion and improved cell survival. The loss of phenotype represents a significant clinical challenge for cell therapies, yet there is no evidence for whether MSC spheroids retain their osteogenic phenotype upon entrapment in a clinically relevant biomaterial. These findings demonstrate that MSC spheroids retain their osteogenic phenotype better than do dissociated MSCs, and this is due to integrin engagement with the cell-secreted extracellular matrix. These data provide evidence for a novel approach for potentiating the use of MSCs in bone repair.
Collapse
Affiliation(s)
- Kaitlin C Murphy
- Department of Biomedical Engineering, University of California, Davis, Davis, California, USA
| | - Allison I Hoch
- Department of Biomedical Engineering, University of California, Davis, Davis, California, USA
| | - Jenna N Harvestine
- Department of Biomedical Engineering, University of California, Davis, Davis, California, USA
| | - Dejie Zhou
- Department of Biomedical Engineering, University of California, Davis, Davis, California, USA
| | - J Kent Leach
- Department of Biomedical Engineering, University of California, Davis, Davis, California, USA Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, California, USA
| |
Collapse
|
14
|
Tasev D, Koolwijk P, van Hinsbergh VWM. Therapeutic Potential of Human-Derived Endothelial Colony-Forming Cells in Animal Models. TISSUE ENGINEERING PART B-REVIEWS 2016; 22:371-382. [PMID: 27032435 DOI: 10.1089/ten.teb.2016.0050] [Citation(s) in RCA: 61] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
PURPOSE OF REVIEW Tissue regeneration requires proper vascularization. In vivo studies identified that the endothelial colony-forming cells (ECFCs), a subtype of endothelial progenitor cells that can be isolated from umbilical cord or peripheral blood, represent a promising cell source for therapeutic neovascularization. ECFCs not only are able to initiate and facilitate neovascularization in diseased tissue but also can, by acting in a paracrine manner, contribute to the creation of favorable conditions for efficient and appropriate differentiation of tissue-resident stem or progenitor cells. This review outlines the progress in the field of in vivo regenerative and tissue engineering studies and surveys why, when, and how ECFCs can be used for tissue regeneration. RECENT FINDINGS Reviewed literature that regard human-derived ECFCs in xenogeneic animal models implicates that ECFCs should be considered as an endothelial cell source of preference for induction of neovascularization. Their neovascularization and regenerative potential is augmented in combination with other types of stem or progenitor cells. Biocompatible scaffolds prevascularized with ECFCs interconnect faster and better with the host vasculature. The physical incorporation of ECFCs in newly formed blood vessels grants prolonged release of trophic factors of interest, which also makes ECFCs an interesting cell source candidate for gene therapy and delivery of bioactive compounds in targeted area. SUMMARY ECFCs possess all biological features to be considered as a cell source of preference for tissue engineering and repair of blood supply. Investigation of regenerative potential of ECFCs in autologous settings in large animal models before clinical application is the next step to clearly outline the most efficient strategy for using ECFCs as treatment.
Collapse
Affiliation(s)
- Dimitar Tasev
- 1 Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center Amsterdam , Amsterdam, The Netherlands .,2 A-Skin Nederland BV , Amsterdam, The Netherlands
| | - Pieter Koolwijk
- 1 Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center Amsterdam , Amsterdam, The Netherlands
| | - Victor W M van Hinsbergh
- 1 Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center Amsterdam , Amsterdam, The Netherlands
| |
Collapse
|
15
|
Bongio M, Lopa S, Gilardi M, Bersini S, Moretti M. A 3D vascularized bone remodeling model combining osteoblasts and osteoclasts in a CaP nanoparticle-enriched matrix. Nanomedicine (Lond) 2016; 11:1073-91. [PMID: 27078586 DOI: 10.2217/nnm-2015-0021] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Abstract
AIM We aimed to establish a 3D vascularized in vitro bone remodeling model. MATERIALS & METHODS Human umbilical endothelial cells (HUVECs), bone marrow mesenchymal stem cells (BMSCs), and osteoblast (OBs) and osteoclast (OCs) precursors were embedded in collagen/fibrin hydrogels enriched with calcium phosphate nanoparticles (CaPn). We assessed vasculogenesis in HUVEC-BMSC coculture, osteogenesis with OBs, osteoclastogenesis with OCs, and, ultimately, cell interplay in tetraculture. RESULTS HUVECs developed a robust microvascular network and BMSCs differentiated into mural cells. Noteworthy, OB and OC differentiation was increased by their reciprocal coculture and by CaPn, and even more by the combination of the tetraculture and CaPn. CONCLUSION We successfully developed a vascularized 3D bone remodeling model, whereby cells interacted and exerted their specific function.
Collapse
Affiliation(s)
- Matilde Bongio
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy
| | - Silvia Lopa
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy
| | - Mara Gilardi
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy.,PhD School in Life Sciences, Department of Biotechnology & Biosciences, University of Milano-Bicocca, 20126 Milan, Italy
| | - Simone Bersini
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy
| | - Matteo Moretti
- Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy.,Regenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale (EOC), 6900 Lugano, Switzerland.,Swiss Institute of Regenerative Medicine (SIRM), 6900 Lugano, Switzerland.,Fondazione Cardiocentro Ticino, 6900 Lugano, Switzerland
| |
Collapse
|
16
|
Hoch AI, Mittal V, Mitra D, Vollmer N, Zikry CA, Leach JK. Cell-secreted matrices perpetuate the bone-forming phenotype of differentiated mesenchymal stem cells. Biomaterials 2016; 74:178-87. [PMID: 26457835 PMCID: PMC4661076 DOI: 10.1016/j.biomaterials.2015.10.003] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2015] [Revised: 09/29/2015] [Accepted: 10/01/2015] [Indexed: 01/13/2023]
Abstract
Prior to transplantation, mesenchymal stem/stromal cells (MSCs) can be induced toward the osteoblastic phenotype using a cocktail of soluble supplements. However, there is little evidence of differentiated MSCs directly participating in bone formation, suggesting that MSCs may either die or revert in phenotype upon transplantation. Cell-secreted decellularized extracellular matrices (DMs) are a promising platform to confer bioactivity and direct cell fate through the presentation of a complex and physiologically relevant milieu. Therefore, we examined the capacity of biomimetic DMs to preserve the mineral-producing phenotype upon withdrawal of the induction stimulus. Regardless of induction duration, ranging up to 6 weeks, MSCs exhibited up to a 5-fold reduction in osteogenic markers within 24 h following stimulus withdrawal. We show that seeding osteogenically induced MSCs on DMs yields up to 2-fold more calcium deposition than tissue culture plastic, and this improvement is at least partially mediated by increasing actin cytoskeletal tension via the ROCK II pathway. MSCs on DMs also secreted 25% more vascular endothelial growth factor (VEGF), a crucial endogenous proangiogenic factor that is abrogated during MSC osteogenic differentiation. The deployment of DMs into a subcutaneous ectopic site enhanced the persistence of MSCs 5-fold, vessel density 3-fold, and bone formation 2-fold more than MSCs delivered without DMs. These results underscore the need for deploying MSCs using biomaterial platforms such as DMs to preserve the in vitro-acquired mineral-producing phenotype and accelerate the process of bone repair.
Collapse
Affiliation(s)
- Allison I Hoch
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States
| | - Vaishali Mittal
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States
| | - Debika Mitra
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States
| | - Nina Vollmer
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States
| | - Christopher A Zikry
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States
| | - J Kent Leach
- Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States; Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, CA 95817, United States.
| |
Collapse
|
17
|
Vissers CAB, Harvestine JN, Leach JK. Pore size regulates mesenchymal stem cell response to Bioglass-loaded composite scaffolds. J Mater Chem B 2015; 3:8650-8658. [PMID: 32262722 DOI: 10.1039/c5tb00947b] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Composite scaffolds fabricated from synthetic polymers and bioceramics such as bioactive glasses are promising alternatives to autogenous bone grafts for treatment of bone defects. Compared to other bioceramics, we previously demonstrated that bioactive glass (Bioglass 45S®, BG) further enhances the osteogenic program of bone-forming osteoblasts when incorporated into poly(lactide-co-glycolide) (PLG) macroporous scaffolds. However, cell response is dependent on parameters beyond scaffold composition including pore size and bioceramic availability to cells. We hypothesized that the osteogenic potential of human mesenchymal stem/stromal cells (MSCs) seeded on BG composite scaffolds was dependent upon pore diameter. Composite BG scaffolds were formed with three pore diameters - 125-300 μm, 300-500 μm, and 500-850 μm - by controlling porogen size. To determine the contribution of pore size to composite scaffold osteogenic potential, we characterized the biophysical properties, bioceramic distribution within the scaffold, and the osteogenic response of MSCs. All composite scaffolds were approximately 2-fold stiffer than the PLG control, and scaffolds with 500-850 μm pore diameters induced the greatest osteogenic response. The enhanced response of MSCs to scaffolds fabricated with large pores resulted from increased presentation of Bioglass along pore surfaces, enabling increased interaction between the cells and bioceramic. These data indicate that cellular behavior is dependent upon both pore size and material composition, confirming that the role of pore size should be considered in the development of new materials designed for bone repair.
Collapse
Affiliation(s)
- Caroline A B Vissers
- Department of Biomedical Engineering, University of California, Davis, 451 Health Sciences Drive, Davis, CA 95616, USA.
| | | | | |
Collapse
|
18
|
Murphy KC, Stilhano RS, Mitra D, Zhou D, Batarni S, Silva EA, Leach JK. Hydrogel biophysical properties instruct coculture-mediated osteogenic potential. FASEB J 2015; 30:477-86. [PMID: 26443826 DOI: 10.1096/fj.15-279984] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Accepted: 09/21/2015] [Indexed: 12/23/2022]
Abstract
Cell-based approaches for bone formation require instructional cues from the surrounding environment. As an alternative to pharmacological strategies or transplanting single cell populations, one approach is to coimplant populations that can establish a new vasculature and differentiate to bone-forming osteoblasts. Mesenchymal stem/stromal cells (MSCs) possess osteogenic potential and produce numerous angiogenic growth factors. Endothelial colony-forming cells (ECFCs) are a subpopulation of endothelial progenitor cells capable of vasculogenesis in vivo and may provide endogenous cues to support MSC function. We investigated the contribution of the carrier biophysical properties to instruct entrapped human MSCs and ECFCs to simultaneously promote their osteogenic and proangiogenic potential. Compared with gels containing MSCs alone, fibrin gels engineered with increased compressive stiffness simultaneously increased the osteogenic and proangiogenic potential of entrapped cocultured cells. ECFCs produced bone morphogenetic protein-2 (BMP-2), a potent osteoinductive molecule, and increases in BMP-2 secretion correlated with gel stiffness. Coculture of MSCs with ECFCs transduced to knockdown BMP-2 production abrogated the osteogenic response to levels observed with MSCs alone. These results demonstrate that physical properties of engineered hydrogels modulate the function of cocultured cells in the absence of inductive cues, thus increasing the translational potential of coimplantation to speed bone formation and repair.
Collapse
Affiliation(s)
- Kaitlin C Murphy
- *Department of Biomedical Engineering and Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Davis, California, USA; and Department of Biophysics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - Roberta S Stilhano
- *Department of Biomedical Engineering and Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Davis, California, USA; and Department of Biophysics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - Debika Mitra
- *Department of Biomedical Engineering and Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Davis, California, USA; and Department of Biophysics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - Dejie Zhou
- *Department of Biomedical Engineering and Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Davis, California, USA; and Department of Biophysics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - Samir Batarni
- *Department of Biomedical Engineering and Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Davis, California, USA; and Department of Biophysics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - Eduardo A Silva
- *Department of Biomedical Engineering and Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Davis, California, USA; and Department of Biophysics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - J Kent Leach
- *Department of Biomedical Engineering and Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Davis, California, USA; and Department of Biophysics, Federal University of Sao Paulo, Sao Paulo, Brazil
| |
Collapse
|
19
|
Nowacki M, Pietkun K, Pokrywczyńska M, Rasmus M, Warda K, Kloskowski T, Jundziłł A, Gagat M, Grzanka A, Bodnar M, Marszałek A, Drewa T, Czajkowski R. Filling effects, persistence, and safety of dermal fillers formulated with stem cells in an animal model. Aesthet Surg J 2014; 34:1261-9. [PMID: 25168156 DOI: 10.1177/1090820x14548212] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Research is scarce regarding the effectiveness of dermal fillers containing autologous stem cells. OBJECTIVES The authors sought to determine the local and systemic effects of adipose-derived stem cells (ADSCs) as a component of dermal fillers in an animal model. METHODS Wistar rats were injected with 1 of the following dermal fillers: ADSCs combined with hyaluronic acid (ADSC-HA), ADSCs combined with fish collagen (ADSC-COL), HA alone (CONTROL-HA), or COL alone (CONTROL-COL). Fillers were injected into the glabella, dorsum, and chest of each animal. The ADSCs were labeled with PKH26 to assess cell migration. Filling effects (FEs) were measured immediately after injection and at 1.5 months and 3 months after injection. Skin specimens were stained with hematoxylin and eosin to assess localization and persistence of ADSCs. RESULTS Mean FEs in animals implanted with ADSCs were greater and persisted longer than those of controls. No inflammatory responses were observed in any group. Three months after injection, PKH26-positive cells comprised nearly 70% of cells at the injection site in animals treated with ADSC-HA. PKH26 fluorescence also was detected in the spleen but not in the brain, kidney, or lung. CONCLUSIONS Stem cells have the potential to improve the aesthetic effects and longevity of dermal fillers.
Collapse
Affiliation(s)
- Maciej Nowacki
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Katarzyna Pietkun
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Marta Pokrywczyńska
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Marta Rasmus
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Karolina Warda
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Tomasz Kloskowski
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Arkadiusz Jundziłł
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Maciej Gagat
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Alina Grzanka
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Magdalena Bodnar
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Andrzej Marszałek
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Tomasz Drewa
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| | - Rafał Czajkowski
- Mr Nowacki is an MD and PhD student, Dr Jundziłł is a volunteer, Dr Pokrywczyńska and Dr Kloskowski are research fellows, and Ms Rasmus and Ms Warda are MSc students in the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, PolandMr Gagat is a research fellow and Dr Grzanka is Professor and Head of the Department of Histology and Embryology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Bodnar is a research fellow in the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland, and Dr Marszałek is Professor and head of the Department of Clinical Pathomorphology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDepartment of Oncologic Pathology, Poznan University of Medical Sciences and Greater Poland Oncology Center, Poznan, PolandMs Pietkun is an MD and PhD student in the Chair of Regenerative Medicine, Department of Tissue Engineering and Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Czajkowski is a Professor and Head of the Department of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, PolandDr Drewa is Professor and Head of the Chair of Regenerative Medicine, Department of Tissue Engineering, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Poland, and Head of the Urology and Oncological Urology Department, Nicolaus Copernicus Hospital, Toruń, Poland
| |
Collapse
|
20
|
Rao RR, Vigen ML, Peterson AW, Caldwell DJ, Putnam AJ, Stegemann JP. Dual-phase osteogenic and vasculogenic engineered tissue for bone formation. Tissue Eng Part A 2014; 21:530-40. [PMID: 25228401 DOI: 10.1089/ten.tea.2013.0740] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
Abstract
Minimally invasive, injectable bone tissue engineering therapies offer the potential to facilitate orthopedic repair procedures, including in indications where enhanced bone regeneration is needed for complete healing. In this study, we developed a dual-phase tissue construct consisting of osteogenic (Osteo) and vasculogenic (Vasculo) components. A modular tissue engineering approach was used to create collagen/fibrin/hydroxyapatite (COL/FIB/HA) hydrogel microbeads containing embedded human bone marrow-derived mesenchymal stem cells (bmMSC). These microbeads were predifferentiated toward the osteogenic lineage in vitro for 14 days, and they were then embedded within a COL/FIB vasculogenic phase containing a coculture of undifferentiated bmMSC and human umbilical vein endothelial cells (HUVEC). In vitro studies demonstrated homogenous dispersion of microbeads within the outer phase, with endothelial network formation around the microbeads over 14 days in the coculture conditions. Subcutaneous injection into immunodeficient mice was used to investigate the ability of dual-phase (Osteo+Vasculo) and control (Osteo, Vasculo, Blank) constructs to form neovasculature and ectopic bone. Laser Doppler imaging demonstrated blood perfusion through all constructs at 1, 4, and 8 weeks postimplantation. Histological quantification of total vessel density showed no significant differences between the conditions. Microcomputed tomography indicated significantly higher ectopic bone volume (BV) in the Osteo condition at 4 weeks. At 8 weeks both the Osteo and Blank groups exhibited higher BV compared to the Vasculo and dual Osteo+Vasculo groups. These data not only show that osteogenic microbeads can be used to induce ectopic bone formation, but also suggest an inhibitory effect on BV when undifferentiated bmMSC and HUVEC were included in dual-phase constructs. This work may lead to improved methods for engineering vascularized bone tissue, and to injectable therapies for the treatment of orthopedic pathologies in which bone regeneration is delayed or prevented.
Collapse
Affiliation(s)
- Rameshwar R Rao
- Department of Biomedical Engineering, University of Michigan , Ann Arbor, Michigan
| | | | | | | | | | | |
Collapse
|
21
|
Rao RR, Ceccarelli J, Vigen ML, Gudur M, Singh R, Deng CX, Putnam AJ, Stegemann JP. Effects of hydroxyapatite on endothelial network formation in collagen/fibrin composite hydrogels in vitro and in vivo. Acta Biomater 2014; 10:3091-7. [PMID: 24657675 DOI: 10.1016/j.actbio.2014.03.010] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2013] [Revised: 03/05/2014] [Accepted: 03/11/2014] [Indexed: 02/05/2023]
Abstract
Co-culture of endothelial cells (EC) and mesenchymal stem cells (MSC) results in robust vascular network formation in constrained 3-D collagen/fibrin (COL/FIB) composite hydrogels. However, the ability to form endothelial networks is lost when such gels are allowed to compact via cell-mediated remodeling. In this study, we created co-cultures of human EC and human MSC in both constrained and unconstrained COL/FIB matrices and systematically added nanoparticulate hydroxyapatite (HA, 0-20 mg ml(-1)), a bone-like mineral that has been shown to have pro-vasculogenic effects. Constructs cultured for 7 days were assayed for gel compaction, vascular network formation, and mechanical properties. In vitro, robust endothelial network formation was observed in constrained COL/FIB constructs without HA, but this response was significantly inhibited by addition of 5, 10, or 20 mg ml(-1) HA. In unconstrained matrices, network formation was abolished in pure COL/FIB constructs but was rescued by 1.25 or 2.5 mg ml(-1) HA, while higher levels again inhibited vasculogenesis. HA inhibited gel compaction in a dose-dependent manner, which was not correlated to endothelial network formation. HA affected initial stiffness of the gels, but gel remodeling abrogated this effect. Subcutaneous implantation of COL/FIB with 0, 2.5 or 2 0mg ml(-1) HA in the mouse resulted in increased perfusion at the implant site, with no significant differences between materials. Histology at day 7 showed both host and human CD31-stained vasculature infiltrating the implants. These findings are relevant to the design of materials and scaffolds for orthopedic tissue engineering, where both vasculogenesis and formation of a mineral phase are required for regeneration.
Collapse
|
22
|
Jose S, Hughbanks ML, Binder BYK, Ingavle GC, Leach JK. Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels. Acta Biomater 2014; 10:1955-64. [PMID: 24468583 DOI: 10.1016/j.actbio.2014.01.020] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2013] [Revised: 12/23/2013] [Accepted: 01/16/2014] [Indexed: 01/15/2023]
Abstract
Recombinant proteins and cytokines are under broad preclinical and clinical investigation to promote angiogenesis, but their success is limited by ineffective delivery, lack of long-term stability and excessive cost. Mesenchymal stem/stromal cells (MSC) secrete bioactive trophic factors, and thus, may provide an effective alternative to address these challenges. Glycine-Histidine-Lysine (GHK) is a peptide fragment of osteonectin, a matricellular protein with reported proangiogenic potential. We examined the capacity of GHK to up-regulate secretion of proangiogenic factors from human MSC in culture and when covalently coupled to alginate hydrogels. GHK had no apparent cytotoxic effects on MSC in culture over a wide range of concentrations. We detected a dose-dependent increase in vascular endothelial growth factor (VEGF) concentration in media conditioned by GHK-treated MSC, which increased endothelial cell proliferation, migration and tubule formation. We covalently coupled GHK to alginate using carbodiimide chemistry, and human MSC were entrapped in alginate hydrogels to assess VEGF secretion. Similar to monolayer culture, MSC responded to GHK-modified gels by secreting increased concentrations of VEGF and basic fibroblast growth factor compared to unmodified gels. The pre-treatment of MSC with antibodies to α6 and β1 integrins prior to entrapment in GHK-modified gels abrogated VEGF secretion, suggesting that the proangiogenic response of MSC was integrin-mediated. These data demonstrate that the proangiogenic potential of MSC can be significantly increased by the presentation of GHK with a biodegradable carrier, therefore increasing their clinical potential when used for tissue repair.
Collapse
Affiliation(s)
- Soumia Jose
- Department of Biomedical Engineering, University of California, Davis, Davis, CA, USA
| | - Marissa L Hughbanks
- Department of Biomedical Engineering, University of California, Davis, Davis, CA, USA
| | - Bernard Y K Binder
- Department of Biomedical Engineering, University of California, Davis, Davis, CA, USA
| | - Ganesh C Ingavle
- Department of Biomedical Engineering, University of California, Davis, Davis, CA, USA
| | - J Kent Leach
- Department of Biomedical Engineering, University of California, Davis, Davis, CA, USA; Department of Orthopaedic Surgery, University of California, Davis, School of Medicine, Sacramento, CA, USA.
| |
Collapse
|
23
|
Murphy KC, Fang SY, Leach JK. Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit improved cell survival and potential for bone healing. Cell Tissue Res 2014; 357:91-9. [PMID: 24781147 DOI: 10.1007/s00441-014-1830-z] [Citation(s) in RCA: 98] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2013] [Accepted: 01/29/2014] [Indexed: 12/16/2022]
Abstract
Mesenchymal stem cells (MSCs) have great therapeutic potential for the repair of nonhealing bone defects, because of their proliferative capacity, multilineage potential, trophic factor secretion and lack of immunogenicity. However, a major challenge to the translation of cell-based therapies into clinical practice is ensuring their survival and function upon implantation into the defect site. We hypothesize that forming MSCs into more physiologic three-dimensional spheroids, rather than employing dissociated cells from two-dimensional monolayer culture, will enhance their survival when exposed to a harsh microenvironment but maintain their osteogenic potential. MSC spheroids were formed by using the hanging drop method with increasing cell numbers. Compared with larger spheroids, the smallest spheroids, which contained 15,000 cells, exhibited increased metabolic activity, reduced apoptosis and the most uniform distribution of proliferating cells. Spheroids were then entrapped in fibrin gels and cultured in serum-free medium and 1 % oxygen. Compared with identical numbers of dissociated MSCs in fibrin gels, spheroids exhibited significantly reduced apoptosis and secreted up to 100-fold more vascular endothelial growth factor. Moreover, fibrin gels containing spheroids and those containing an equivalent number of dissociated cells exhibited similar expression levels of early and late markers of osteogenic differentiation. Thus, MSC spheroids exhibit greater resistance to apoptosis and enhanced proangiogenic potential while maintaining similar osteogenic potential to dissociated MSCs entrapped in a clinically relevant biomaterial, supporting the use of MSC spheroids in cell-based approaches to bone repair.
Collapse
Affiliation(s)
- Kaitlin C Murphy
- Department of Biomedical Engineering, University of California, 451 Health Sciences Drive, Davis, CA, 95616, USA
| | | | | |
Collapse
|
24
|
Binder BYK, Genetos DC, Leach JK. Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis. Tissue Eng Part A 2014; 20:1156-64. [PMID: 24131310 DOI: 10.1089/ten.tea.2013.0487] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
The survival of transplanted cells and their resulting efficacy in cell-based therapies is markedly impaired due to serum deprivation and hypoxia (SD/H) resulting from poor vascularization within tissue defects. Lysophosphatidic acid (LPA) is a platelet-derived growth factor with pleiotropic effects on many cell types. Mesenchymal stromal cells (MSC) exhibit unique secretory and stimulatory characteristics depending on their differentiation state. In light of the potential of MSC in cell-based therapies, we examined the ability of LPA to abrogate SD/H-induced apoptosis in human MSC at increasing stages of osteogenic differentiation in vitro and assessed MSC survival in vivo. Undifferentiated MSC were rescued from SD/H-induced apoptosis by treatment with both 25 and 100 μM LPA. However, MSC conditioned with osteogenic supplements responded to 25 μM LPA, and cells conditioned with dexamethasone-containing osteogenic media required 100 μM LPA. This rescue was mediated through LPA1 in all cases. The addition of 25 μM LPA enhanced vascular endothelial growth factor (VEGF) secretion by MSC in all conditions, but VEGF availability was not responsible for protection against apoptosis. We also showed that codelivery of 25 μM LPA with MSC in alginate hydrogels significantly improved the persistence of undifferentiated MSC in vivo over 4 weeks as measured by bioluminescence imaging. Osteogenic differentiation alone was protective of SD/H-induced apoptosis in vitro, and the synergistic delivery of LPA did not enhance persistence of osteogenically induced MSC in vivo. These data demonstrate that the capacity of LPA to inhibit SD/H-induced apoptosis in MSC is dependent on both the differentiation state and dosage. This information will be valuable for optimizing osteogenic conditioning regimens for MSC before in vivo implementation.
Collapse
Affiliation(s)
- Bernard Y K Binder
- 1 Department of Biomedical Engineering, University of California , Davis, Davis, California
| | | | | |
Collapse
|
25
|
Ingavle GC, Leach JK. Advancements in electrospinning of polymeric nanofibrous scaffolds for tissue engineering. TISSUE ENGINEERING PART B-REVIEWS 2013; 20:277-93. [PMID: 24004443 DOI: 10.1089/ten.teb.2013.0276] [Citation(s) in RCA: 145] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Polymeric nanofibers have potential as tissue engineering scaffolds, as they mimic the nanoscale properties and structural characteristics of native extracellular matrix (ECM). Nanofibers composed of natural and synthetic polymers, biomimetic composites, ceramics, and metals have been fabricated by electrospinning for various tissue engineering applications. The inherent advantages of electrospinning nanofibers include the generation of substrata with high surface area-to-volume ratios, the capacity to precisely control material and mechanical properties, and a tendency for cellular in-growth due to interconnectivity within the pores. Furthermore, the electrospinning process affords the opportunity to engineer scaffolds with micro- to nanoscale topography similar to the natural ECM. This review describes the fundamental aspects of the electrospinning process when applied to spinnable natural and synthetic polymers; particularly, those parameters that influence fiber geometry, morphology, mesh porosity, and scaffold mechanical properties. We describe cellular responses to fiber morphology achieved by varying processing parameters and highlight successful applications of electrospun nanofibrous scaffolds when used to tissue engineer bone, skin, and vascular grafts.
Collapse
Affiliation(s)
- Ganesh C Ingavle
- 1 Department of Biomedical Engineering, University of California Davis , Davis, California
| | | |
Collapse
|
26
|
Bhat A, Hoch AI, Decaris ML, Leach JK. Alginate hydrogels containing cell‐interactive beads for bone formation. FASEB J 2013; 27:4844-52. [DOI: 10.1096/fj.12-213611] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Archana Bhat
- Department of Biomedical EngineeringUniversity of California–DavisDavisCaliforniaUSA
| | - Allison I. Hoch
- Department of Biomedical EngineeringUniversity of California–DavisDavisCaliforniaUSA
| | - Martin L. Decaris
- Department of Biomedical EngineeringUniversity of California–DavisDavisCaliforniaUSA
| | - J. Kent Leach
- Department of Biomedical EngineeringUniversity of California–DavisDavisCaliforniaUSA
- Department of Orthopaedic SurgeryUniversity of California–Davis School of MedicineSacramentoCaliforniaUSA¼
| |
Collapse
|
27
|
Hatsushika D, Muneta T, Horie M, Koga H, Tsuji K, Sekiya I. Intraarticular injection of synovial stem cells promotes meniscal regeneration in a rabbit massive meniscal defect model. J Orthop Res 2013; 31:1354-9. [PMID: 23595964 DOI: 10.1002/jor.22370] [Citation(s) in RCA: 70] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2012] [Accepted: 03/13/2013] [Indexed: 02/04/2023]
Abstract
We investigated whether single intraarticular injection of synovial MSCs enhanced meniscal regeneration in a rabbit massive meniscal defect model. Synovium were harvested from the knee joint of rabbits, and the colony-forming cells were collected. Two weeks after the anterior half of the medial menisci were excised in both knees, 1 × 10(7) MSCs in 100 μl PBS were injected into the right knee. The MSC and control groups were compared macroscopically and histologically at 1, 3, 4, and 6 months (n = 4). Articular cartilage of the medial femoral condyle was also evaluated histologically at 6 months. Multipotentiality of the colony-forming cells was confirmed. Injected MSCs labeled with DiI were detected and remained in the meniscal defect at 14 days. The size of meniscus in the MSC group was larger than that in the control group at 1 and 3 months. The difference of the size between the two groups was indistinct at 4 and 6 months. However, histological score was better in the MSC group than in the control group at 1, 3, 4, and 6 months. Macroscopically, the surface of the medial femoral condyle in the control group was fibrillated at 6 months, while looked close to intact in the MSC group. Histologically, defect or thinning of the articular cartilage with sclerosis of the subchondral bone was observed in the control group, contrarily articular cartilage and subchondral bone were better preserved in the MSC group. Synovial MSCs injected into the knee adhered around the meniscal defect, and promoted meniscal regeneration in rabbits.
Collapse
Affiliation(s)
- Daisuke Hatsushika
- Department of Joint Surgery and Sports Medicine, Tokyo Medical and Dental University, Tokyo, Bunkyo-ku, Japan
| | | | | | | | | | | |
Collapse
|
28
|
Cell-based approaches to the engineering of vascularized bone tissue. Cytotherapy 2013; 15:1309-22. [PMID: 23999157 DOI: 10.1016/j.jcyt.2013.06.005] [Citation(s) in RCA: 62] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2013] [Revised: 06/04/2013] [Accepted: 06/17/2013] [Indexed: 01/14/2023]
Abstract
This review summarizes recent efforts to create vascularized bone tissue in vitro and in vivo through the use of cell-based therapy approaches. The treatment of large and recalcitrant bone wounds is a serious clinical problem, and in the United States approximately 10% of all fractures are complicated by delayed union or non-union. Treatment approaches with the use of growth factor and gene delivery have shown some promise, but results are variable and clinical complications have arisen. Cell-based therapies offer the potential to recapitulate key components of the bone-healing cascade, which involves concomitant regeneration of vasculature and new bone tissue. For this reason, osteogenic and vasculogenic cell types have been combined in co-cultures to capitalize on the function of each cell type and to promote heterotypic interactions. Experiments in both two-dimensional and three-dimensional systems have provided insight into the mechanisms by which osteogenic and vasculogenic cells interact to form vascularized bone, and these approaches have been translated to ectopic and orthotopic models in small-animal studies. The knowledge generated by these studies will inform and facilitate the next generation of pre-clinical studies, which are needed to move cell-based orthopaedic repair strategies into the clinic. The science and application of cytotherapy for repair of large and ischemic bone defects is developing rapidly and promises to provide new treatment methods for these challenging clinical problems.
Collapse
|
29
|
Davis HE, Binder BY, Schaecher P, Yakoobinsky DD, Bhat A, Leach JK. Enhancing osteoconductivity of fibrin gels with apatite-coated polymer microspheres. Tissue Eng Part A 2013; 19:1773-82. [PMID: 23560390 PMCID: PMC3700018 DOI: 10.1089/ten.tea.2012.0288] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2012] [Accepted: 03/08/2013] [Indexed: 10/27/2022] Open
Abstract
Fibrin gels are a promising material for use in promoting bone repair and regeneration due to their ease of implant formation, tailorability, biocompatibility, and degradation by natural processes. However, these materials lack necessary osteoconductivity to nucleate calcium, integrate with surrounding bone, and promote bone formation. Polymeric substrata formed from poly(lactide-co-glycolide) (PLG) are widely used in bone tissue engineering. A carbonated apatite layer of bone-like mineral can be successfully grown on the surface of PLG microspheres after a multiday incubation process in modified simulated body fluid. Such coatings improve the osteoconductivity of the polymer, provide nucleation sites for cell-secreted calcium, and enhance the potential osseointegration with host tissue. We examined the capacity of mineralized polymeric microspheres suspended within fibrin hydrogels to enhance the osteoconductivity of fibrin gels and increase the osteogenic potential of these materials. The inclusion of microparticles, both nonmineralized and mineralized, reduced the capacity of mesenchymal stem cells (MSCs) to contract the gel. When cultured in osteogenic media, we detected a near linear increase in both calcium and phosphate incorporation in gels containing mineralized microspheres and entrapped MSCs. The osteoconductivity of acellular fibrin gels with mineralized and nonmineralized microspheres was assessed in a rodent calvarial bone defect over 12 weeks. Compared to untreated rodent calvarial bone defects, we detected significant increases in early vascularization when treated with fibrin gels, with greater vascularization, on average, occurring with gels containing microspheres. We detected a trend for increased bone mineral density in gels containing mineralized microspheres after 12 weeks. These findings demonstrate that the osteoconductivity of fibrin gels can be increased by inclusion of mineralized microspheres, but additional signals may be required to rapidly accelerate bone repair.
Collapse
Affiliation(s)
- Hillary E. Davis
- Biomedical Engineering Graduate Group, University of California Davis, Davis, California
| | - Bernard Y.K. Binder
- Biomedical Engineering Graduate Group, University of California Davis, Davis, California
| | - Phillip Schaecher
- Department of Biomedical Engineering, University of California Davis, Davis, California
| | - Dana D. Yakoobinsky
- Department of Biomedical Engineering, University of California Davis, Davis, California
| | - Archana Bhat
- Department of Biomedical Engineering, University of California Davis, Davis, California
| | - J. Kent Leach
- Biomedical Engineering Graduate Group, University of California Davis, Davis, California
- Department of Biomedical Engineering, University of California Davis, Davis, California
- Department of Orthopaedic Surgery, School of Medicine, University of California Davis, Sacramento, California
| |
Collapse
|
30
|
Kampmann A, Lindhorst D, Schumann P, Zimmerer R, Kokemüller H, Rücker M, Gellrich NC, Tavassol F. Additive effect of mesenchymal stem cells and VEGF to vascularization of PLGA scaffolds. Microvasc Res 2013; 90:71-9. [PMID: 23899416 DOI: 10.1016/j.mvr.2013.07.006] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2013] [Revised: 07/05/2013] [Accepted: 07/17/2013] [Indexed: 11/20/2022]
Abstract
Bone marrow derived mesenchymal stem cells (bmMSCs) are widely used for the generation of tissue engineering constructs, since they can differentiate into different cell types occurring in bone tissues. Until now their use for the generation of tissue engineering constructs is limited. All cells inside a tissue engineering construct die within a short period of time after implantation of the construct because vascularization and establishment of connections to the recipient circulatory system is a time consuming process. We therefore compared the influences of bmMSC, VEGF and a combination of both on the early processes of vascularization, utilizing the mice skinfold chamber model and intravital fluorescence microscopy. Tissue engineering constructs based on collagen coated Poly d,l-lactide-co-glycolide (PLGA) scaffolds, were either functionalized by coating with vascular endothelial growth factor (VEGF) or vitalized with bmMSC. PLGA without cells and growth factor was used as the control group. Functionalized and vitalized tissue engineering constructs showed an accelerated growth of microvessels compared to controls. Only marginal differences in vascular growth were detected between VEGF containing and bmMSC containing constructs. Constructs containing VEGF and bmMSC showed a further enhanced microvascular growth at day 14. We conclude that bmMSCs are well suited for bone tissue engineering applications, since they are a valuable source of angiogenic growth factors and are able to differentiate into the tissue specific cell types of interest. The dynamic process of vascularization triggered by growth factor producing cells can be amplified and stabilized with the addition of accessory growth factors, leading to a persisting angiogenesis, but strategies are needed that enhance the resistance of bmMSC to hypoxia and increase survival of these cells until the tissue engineering construct has build up a functional vascular system.
Collapse
Affiliation(s)
- Andreas Kampmann
- Department of Oral and Maxillofacial Surgery, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
31
|
Chen SH, Lei M, Xie XH, Zheng LZ, Yao D, Wang XL, Li W, Zhao Z, Kong A, Xiao DM, Wang DP, Pan XH, Wang YX, Qin L. PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits. Acta Biomater 2013; 9:6711-22. [PMID: 23376238 DOI: 10.1016/j.actbio.2013.01.024] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2012] [Revised: 01/22/2013] [Accepted: 01/23/2013] [Indexed: 12/18/2022]
Abstract
Bone defect repair is challenging in orthopaedic clinics. For treatment of large bone defects, bone grafting remains the method of choice for the majority of surgeons, as it fills spaces and provides support to enhance biological bone repair. As therapeutic agents are desirable for enhancing bone healing, this study was designed to develop such a bioactive composite scaffold (PLGA/TCP/ICT) made of polylactide-co-glycolide (PLGA) and tricalcium phosphate (TCP) as a basic carrier, incorporating a phytomolecule icaritin (ICT), i.e., a novel osteogenic exogenous growth factor. PLGA/TCP/ICT scaffolds were fabricated as PLGA/TCP (control group) and PLGA/TCP in tandem with low/mid/high-dose ICT (LICT/MICT/HICT groups, respectively). To evaluate the in vivo osteogenic and angiogenic potentials of these bioactive scaffolds with slow release of osteogenic ICT, the authors established a 12 mm ulnar bone defect model in rabbits. X-ray and high-resolution peripheral quantitative computed tomography results at weeks 2, 4 and 8 post-surgery showed more newly formed bone within bone defects implanted with PLGA/TCP/ICT scaffolds, especially PLGA/TCP/MICT scaffold. Histological results at weeks 4 and 8 also demonstrated more newly mineralized bone in PLGA/TCP/ICT groups, especially in the PLGA/TCP/MICT group, with correspondingly more new vessel ingrowth. These findings may form a good foundation for potential clinical validation of this innovative bioactive scaffold incorporated with the proper amount of osteopromotive phytomolecule ICT as a ready product for clinical applications.
Collapse
Affiliation(s)
- S-H Chen
- Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Ceramic identity contributes to mechanical properties and osteoblast behavior on macroporous composite scaffolds. J Funct Biomater 2012; 3:382-97. [PMID: 24955539 PMCID: PMC4047943 DOI: 10.3390/jfb3020382] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2012] [Revised: 04/27/2012] [Accepted: 05/17/2012] [Indexed: 11/28/2022] Open
Abstract
Implants formed of metals, bioceramics, or polymers may provide an alternative to autografts for treating large bone defects. However, limitations to each material motivate the examination of composites to capitalize on the beneficial aspects of individual components and to address the need for conferring bioactive behavior to the polymer matrix. We hypothesized that the inclusion of different bioceramics in a ceramic-polymer composite would alter the physical properties of the implant and the cellular osteogenic response. To test this, composite scaffolds formed from poly(lactide-co-glycolide) (PLG) and either hydroxyapatite (HA), β-tricalcium phosphate (TCP), or bioactive glass (Bioglass 45S®, BG) were fabricated, and the physical properties of each scaffold were examined. We quantified cell proliferation by DNA content, osteogenic response of human osteoblasts (NHOsts) to composite scaffolds by alkaline phosphatase (ALP) activity, and changes in gene expression by qPCR. Compared to BG-PLG scaffolds, HA-PLG and TCP-PLG composite scaffolds possessed greater compressive moduli. NHOsts on BG-PLG substrates exhibited higher ALP activity than those on control, HA-, or TCP-PLG scaffolds after 21 days, and cells on composites exhibited a 3-fold increase in ALP activity between 7 and 21 days versus a minimal increase on control scaffolds. Compared to cells on PLG controls, RUNX2 expression in NHOsts on composite scaffolds was lower at both 7 and 21 days, while expression of genes encoding for bone matrix proteins (COL1A1 and SPARC) was higher on BG-PLG scaffolds at both time points. These data demonstrate the importance of selecting a ceramic when fabricating composites applied for bone healing.
Collapse
|